Lung Biotechnology Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Lung Biotechnology General Information

Description

Developer of healthcare therapies designed to simplify and democratize the treatment of lung disease. The company's therapies seek to increase access and improve outcomes after lung transplantation for people with PAH and other fatal lung diseases, enabling patients to receive beneficial treatment for pulmonary diseases.

Contact Information

Formerly Known As
Lung Rx
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1040 Spring Street
  • Silver Spring, MD 20910
  • United States
+1 (301)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1040 Spring Street
  • Silver Spring, MD 20910
  • United States
+1 (301)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lung Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 03-Nov-2023 Completed Generating Revenue
2. Later Stage VC (Series B) 01-Jan-2016 Completed Generating Revenue
1. Later Stage VC (Series A) 01-Jan-2015 $10M $10M Completed Generating Revenue
To view Lung Biotechnology’s complete valuation and funding history, request access »

Lung Biotechnology Patents

Lung Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024286647-A1 A high resolution printing system and a method of aligning pixelated tiles Pending 06-Jun-2023
EP-4724258-A1 A high resolution printing system and a method of aligning pixelated tiles Pending 06-Jun-2023
WO-2024254170-A1 A high resolution printing system and a method of aligning pixelated tiles Inactive 06-Jun-2023
US-20240408826-A1 High resolution printing system and a method of aligning pixelated tiles Pending 06-Jun-2023
AU-2024265057-A1 Media composition for induced pluripotent stem cell derived endothelial cell growth, monolayer formation, and cell-cell contact formation Pending 03-May-2023 C12N5/0696
To view Lung Biotechnology’s complete patent history, request access »

Lung Biotechnology Investments (2)

Lung Biotechnology’s most recent deal was a Later Stage VC with TransMedics Group for . The deal was made on 11-Jul-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TransMedics Group 11-Jul-2016 Later Stage VC Other Devices and Supplies
Viridos 06-May-2014 Later Stage VC Other Agriculture
To view Lung Biotechnology’s complete investments history, request access »

Lung Biotechnology FAQs

  • When was Lung Biotechnology founded?

    Lung Biotechnology was founded in 2006.

  • Where is Lung Biotechnology headquartered?

    Lung Biotechnology is headquartered in Silver Spring, MD.

  • What industry is Lung Biotechnology in?

    Lung Biotechnology’s primary industry is Drug Discovery.

  • Is Lung Biotechnology a private or public company?

    Lung Biotechnology is a Private company.

  • What is Lung Biotechnology’s current revenue?

    The current revenue for Lung Biotechnology is .

  • How much funding has Lung Biotechnology raised over time?

    Lung Biotechnology has raised $52M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process